METHOD FOR DETECTING CONTENTS OF WHEY PROTEIN AND CASEIN, AND/OR RATIO THEREOF IN MILK POWDER

INCORPORATION BY REFERENCE

The sequence listing provided in the file entitled C6160-022_SQL.xml, which is an Extensible Markup Language (XML) file that was created on Aug. 22, 2022, and which comprises 4,311 bytes, is hereby incorporated by reference in its entirety.

TECHNICAL FIELD

The present disclosure relates to the technical field of food detection, and in particular to a method for detecting the contents of whey protein and casein, and/or the ratio thereof in milk powder by liquid chromatography-mass spectrometry.

BACKGROUND ART

Whey protein, as one of the main nutrients in infant formula milk powder, accounts for a particularly important nutritional proportion of the formula milk powder. The main ingredients of whey protein are shown in the following table:

TABLE 1

Main ingredients of whey protein

Relative

Whey
Proportion
molecular
Isoelectric

protein
(%)
mass
point
Function

α-La
20~25%
14.2
4.20-4.50
binding to metal ions including calcium;

contributing to the transportation and

absorption of calcium; participating in the

synthesis of lactose; regulating

neurotransmitters to help sleep; promoting

infant brain development; having

anti-cancer effect.

β-Lg
50-55%
18.3
5.35-5.49
binding to fat-soluble vitamins and fatty

acids and transporting them; participating

in the synthesis of prostaglandin-related

enzymes, and having antihypertensive and

antitumor effects.

Ig
10-15%
<150.0
5.50-8.30
resisting to microbial pathogens and

toxins, and being one important

component of human immunity; being

able to protect breast from infection.

BSA
5-10%
66.4
5.13
participating in the transport, metabolism,

and distribution of ligands; regulating

blood osmotic pressure.

Whey protein contains a variety of essential amino acids required by human body, and exhibits high bioavailability. It contains one third of branched-chain amino acids (leucine, isoleucine, and valine, etc.), which not only provide energy for the body, but also have been proved to be one of the important precursors for the synthesis of glutamate in human body. In addition, leucine can also participate in the intracellular metabolic pathways regulating synthesis of skeletal muscle protein, thus enhancing the synthesis of skeletal muscle protein.

Whey protein is also an important source of sulfur-containing amino acids (cysteine) in human body, which are important precursors for making up glutathione and taurine. Glutathione plays a key role in free radical scavenging and immune response. Glutathione, as well as taurine, can inhibit lipid peroxidation and play an antioxidant role. Threonine in whey protein is converted directly into intestinal mucin after being taken up by intestinal tract, thus providing protection for intestinal cells as well as intestinal barrier integrity. Finally, lysine and arginine in whey protein can promote muscle growth by stimulating secretion of metabolic hormones in the body.

As an important detection index for formula milk powder, it is stipulated by the national food safety standard GB 10765-2010 that the content of whey protein in infant formula milk powder should exceed 60%. Due to the complex additives in infant formula milk powder and the heating process in the production thereof, changes in the space structures of whey and casein proteins may occur, for example, a disulfide bond unfolds, resulting in protein aggregation, and thus forming polymers of various proteins, which makes the detection of whey protein in formula milk powder extremely difficult.

At present, many methods have been applied to detect the content of whey protein. However, among these methods, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, high performance liquid chromatography, high performance capillary electrophoresis, etc., are all affected by protein denaturation occurred in the production thereof, resulting in an inaccurate quantification of whey protein, i.e. a large deviation in the measurement results; the amino acid conversion method, which is usually used to determine the content of whey protein, has a narrow application range and is easily affected by additives; and the liquid chromatography detection method using isotope internal standard cannot be widely used in practical production due to the need to synthesize internal standard isotopes which produces high detection cost.

Casein protein is one of the main proteins in milk, and can be hydrolyzed into a variety of bioactive peptides after being digested in gastrointestinal tract. At present, detection of casein protein in formula milk powder is mainly performed by high performance liquid chromatography, in which, however, casein protein shows a less desirable peak shape in high performance liquid phase, and it is difficult to distinguish the chromatographic peak of κ-casein from that of a s₂-casein. Enzyme-linked immunosorbent assay (ELISA) and liquid chromatography-mass spectrometry (LC-MS) and the like have also been proposed in succession, and they show a good performance in the detection of casein protein.

The information disclosed in the Background section is only intended to facilitate understanding of the general background of the present disclosure and should not be taken as an acknowledgment or implying, in any form, that the information constitutes the prior art already known to a person with ordinary skill in the art.

SUMMARY OF THE INVENTION
Purpose

In view of the disadvantages of the current detection methods as mentioned above, the present disclosure aims to provide a method for detecting the contents of whey protein and casein, and/or the ratio thereof in milk powder by liquid chromatography-mass spectrometry. According to the method of the present disclosure, the accuracy and stability of detecting peptide segments by mass spectrometry using external standards can be improved by selecting the respective characteristic peptide segments of whey protein and casein, and using the same for correction.

Solutions

In order to achieve the purpose of the invention, the technical solutions provided by the present disclosure are as follows.

In one aspect, provided is a method for detecting the contents of whey protein and casein, and/or the ratio thereof in milk powder by liquid chromatography-mass spectrometry, which comprises:

1) preparing a standard solution of whey protein with the characteristic peptide segments of α-lactalbumin and β-lactoglobulin, in accordance with the α-lactalbumin and β-lactoglobulin accounting for 20% and 50% of the whey protein, respectively;

2) preparing a standard solution of casein protein with the characteristic peptide segments of α-casein and β-casein, in accordance with the α-casein and β-casein accounting for 50% and 40% of the casein protein, respectively;

3) mixing the standard solution of whey protein from step 1) with the standard solution of casein protein from step 2) to prepare a series of mixed protein standard solutions with a series of whey protein:casein ratios;

4) drawing standard curves with the ratios of whey protein to casein as abscissa and the peak area ratios of characteristic peptide segments of α-lactalbumin to β-casein and those of β-lactoglobulin to α-casein as ordinate;

5) detecting the milk powder to be tested for the peak area ratios of characteristic peptide segments of β-lactoglobulin to α-casein and those of α-lactalbumin to β-casein;

6) substituting the peak area ratio of the characteristic peptide segments of β-lactoglobulin to α-casein in the detected milk powder into the standard curve to determine the ratio M of whey protein to casein, and calculate the actual amounts of β-lactoglobulin and α-casein based on the ratio M thus determined;

and, substituting the peak area ratio of the characteristic peptide segments of α-lactalbumin to β-casein in the detected milk powder into the standard curve to determine the ratio N of whey protein to casein, and calculate the actual amounts of α-lactalbumin to β-casein based on the ratio N thus determined;

7) acquiring the actual contents of whey protein and casein, and/or the actual ratio of whey protein/casein based on the actual amounts of α-lactalbumin, β-casein, β-lactoglobulin, and α-casein obtained from step 6).

In the above method, preferably, the characteristic peptide segments of α-lactalbumin, β-casein, β-lactoglobulin, and α-casein are LDQWLCEK shown in SEQ ID NO.1, VLPVPQK shown in SEQ ID NO.2, TPEVDDEALEK shown in SEQ ID NO.3, and FALPQYLK shown in SEQ ID NO.4, respectively.

Preferably, in step 3), the series of whey protein:casein ratios include whey protein:casein ratios of 0.25, 0.43, 0.67, 1, 1.5, and 2.33, respectively.

Preferably, in step 6), the actual amounts of β-lactoglobulin and α-casein are calculated by the following formulas, respectively:

$β - lactoglobulin = \frac{M 1}{M 1 + M 2} X * 50 %, α - casein = \frac{M 2}{M 1 + M 2} X * 50 %;$

wherein, M1 is the preceding term in the ratio M of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of β-lactoglobulin to α-casein, and M2 is the latter term in the ratio M of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of β-lactoglobulin to α-casein, with the provisions of: M=M1/M2, and M1+M2=1; and,

wherein, X is the total protein concentration of the sample.

Preferably, in step 6), the actual amounts of α-lactalbumin and β-casein are calculated by the following formulas:

$α - la = \frac{N 1}{N 1 + N 2} X * 20 %, β - cs = \frac{N 2}{N 1 + N 2} X * 40 %;$

wherein, N1 is the preceding term in the ratio N of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of α-lactalbumin to β-casein, and N2 is the latter term in the ratio N of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of α-lactalbumin to β-casein, with the provisions of: N=N1/N2, and N1+N2=1; and,

wherein, X is the total protein concentration of the sample.

Preferably, in step 7),

the formula for calculating the actual content of whey protein is:

$\frac{\frac{N 1}{N 1 + N 2} X * 20 % + \frac{M 1}{M 1 + M 2} X * 50 %}{0.7}$

the formula for calculating the actual content of casein is:

$\frac{\frac{M 1}{M 1 + M 2} X * 50 % + \frac{N 2}{N 1 + N 2} X * 40 %}{0.9}$

the formula for calculating the actual ratio of whey protein/casein is:

$\frac{\frac{N 1}{N 1 + N 2} X * 20 % + \frac{M 1}{M 1 + M 2} X * 50 %}{0.7} ⁠ / \frac{\frac{M 2}{M 1 + M 2} X * 50 % + \frac{N 2}{N 1 + N 2} X * 40 %}{0.9} = \frac{18 N 1 + 45 M 1}{35 M 2 + 28 N 2} = \frac{63 MN + 18 N + 45 M}{35 N + 28 M + 63};$

wherein, X is the total protein concentration of the sample.

Preferably, the detection in step 5) comprises the steps of sample treatment and enzyme digestion:dissolving the milk powder sample to be tested into a sample solution with a protein concentration of 0.1-0.4 mg/mL, preferably 0.2 mg/mL; subjecting the sample solution to rough filtration with a pure acetic acid filter membrane preferably with a pore size of 0.45 μm; adding the roughly filtered sample solution into ammonium bicarbonate solution, followed by adding dithiothreitol solution, and standing in a water bath at 65-75° C., preferably 70° C. for 25-35 min, preferably 30 min; after cooling, adding iodoacetamide solution, and standing for 25-35 min, preferably 30 min in the dark; illuminating the mixture for 8-12 min, preferably 10 min, followed by adding calcium chloride solution; then adding trypsin solution to allow an enzyme digestion at 37° C. for 26-30 h; then adding acetic acid solution to stop the enzyme digestion; filtering the reaction mixture with polyethersulfone filter membrane, and then performing selective ion scanning analysis by mass spectrometry.

In a specific embodiment, the upper detection limit of the method of the present disclosure is at a total protein concentration of 0.4 mg/mL.

In a second aspect, provided is a combination of characteristic peptide segments for detecting the ratio of whey protein:casein by liquid chromatography-mass spectrometry, comprising: characteristic peptide segments of α-lactalbumin, β-casein, β-lactoglobulin, and α-casein with amino acid sequences as shown in SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, and SEQ ID NO.4, respectively.

In a specific embodiment, the combination of characteristic peptide segments consists of characteristic peptide segments of α-lactalbumin, β-casein, β-lactoglobulin, and α-casein with amino acid sequences as shown in SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 and SEQ ID NO.4, respectively.

Beneficial Effects

Compared with the prior art, the relative quantitative method for detecting the contents of whey protein and casein, and/or the ratio thereof in milk powder has high accuracy and stability, and in addition, it has the following advantages: easy to pretreat samples, low cost, a wide range of applicability, enable to perform quantitative detection of whey protein at one time, not affected by protein denaturation in the production process, no need to synthesize isotope internal standard, and avoiding influence of ionization efficiency and matrix in mass spectrometry detection by means of their own multiple characteristic peptide segment ratios.

BRIEF DESCRIPTION OF THE DRAWINGS

One or more examples are exemplified by the pictures in the accompanying drawings that correspond thereto and are not intended to be limiting of the embodiments. As used herein, the word “exemplary” means “serving as an example, embodiment, or illustrative”. Any embodiment described herein as “exemplary” is not necessarily to be construed as superior or better than other embodiments.

FIG. 1 is a full scanning mass spectrum of the mixed standard substance used in the Example;

FIG. 2 is a full scanning mass spectrum of the milk powder sample;

FIG. 3 is the mass spectrum of four characteristic peptide segments in PRM mode;

FIG. 4 is the full fragment ion diagram of the characteristic peptide segment (LDQWLCEK) shown in SEQ ID NO.1;

FIG. 5 is the full fragment ion diagram of the characteristic peptide segment (TPEVDDEALEK) shown in SEQ ID NO.3;

FIG. 6 is the full fragment ion diagram of the characteristic peptide segment (FALPQYLK) shown in SEQ ID NO.4;

FIG. 7 is the full fragment ion diagram of the characteristic peptide segment (VLPVPQK) shown in SEQ ID NO.2;

FIG. 8 is a quantitative daughter ion peak profile of four characteristic peptide segments;

FIG. 9 shows the change of peak area ratio of characteristic peptide segments LDQWLCEK(SEQ ID NO.1)/VLPVPQK(SEQ ID NO.2) at different enzyme concentrations and with different enzymolysis time, with the enzymolysis time as abscissa, and the peak area ratio of two characteristic peptide segments as ordinate;

FIG. 10 shows the change of peak area ratio of characteristic peptide segments TPEVDDEALEK(SEQ ID NO.3)/FALPQYLK(SEQ ID NO.4) at different enzyme concentrations and with different enzymolysis time, with the enzymolysis time as abscissa, and the peak area ratio of two characteristic peptide segments as ordinate;

FIG. 11 shows the impact of different substrate concentrations on the peak area ratio of characteristic peptide segments LDQWLCEK(SEQ ID NO.1)/VLPVPQK(SEQ ID NO.2) at an enzyme concentration of 1:20 with enzymolysis time of 28 h, with the substrate concentration as abscissa, and the peak area ratio of two characteristic peptide segments as ordinate;

FIG. 12 shows the impact of different substrate concentrations on the peak area ratio of characteristic peptide segments TPEVDDEALEK(SEQ ID NO.3)/FALPQYLK(SEQ ID NO.4) at an enzyme concentration of 1:20 with enzymolysis time of 28 h, with the substrate concentration as abscissa, and the peak area ratio of two characteristic peptide segments as ordinate;

FIG. 13 is a standard curve of peak area ratio vs concentration ratio of characteristic peptide segments TPEVDDEALEK(SEQ ID NO.3)/FALPQYLK(SEQ ID NO.4), with the concentration ratio of two characteristic peptide segments as abscissa, and the peak area ratio thereof as ordinate; and R2 of the standard curve regression equation is 0.9935;

FIG. 14 is a standard curve of peak area ratio vs concentration ratio of characteristic peptide segments LDQWLCEK(SEQ ID NO.1)/VLPVPQK(SEQ ID NO.2), with the concentration ratio of two characteristic peptide segments as abscissa, and the peak area ratio thereof as ordinate; and R2 of the standard curve regression equation is 0.992;

FIG. 15 is a primary mass spectrum of desalted whey powder;

FIG. 16 shows the composition of desalted whey powder protein.

DETAILED DESCRIPTION OF THE INVENTION

In order to make the purpose, technical solutions, and advantages of the embodiments of the invention clearer, the technical solutions in the embodiments of the present disclosure will be described clearly and completely, obviously, the described embodiments are some of the embodiments of the present disclosure, but not all of them. Based on the embodiments of the present disclosure, all other embodiments obtained by those of ordinary skill in the art without creative work are within the scope of the present invention.

In addition, in order to better explain the present invention, a lot of specific details are given in the following embodiments. It will be understood by those skilled in the art that the present invention may be practiced without certain specific details. In some embodiments, materials, elements, methods, means, etc., well known to those skilled in the art, are not described in detail so as to highlight the spirit of the present invention.

Throughout the specification and claims, the term “comprising” or variations thereof, such as “including” or “containing” and the like, will be understood to include the stated components and not to exclude other elements or other components, unless expressly indicated otherwise.

In the following examples, the reagents used were as follows:

Dithiothreitol (sigma, ≥98% HPLC); iodoacetamide (sigma, ≥99% NMR); α-lactalbumin standard substance (sigma, ≥85%); β-lactoglobulin standard substance (sigma, ≥90%); α-casein standard substance (sigma, ≥70%); β-casein standard substance (sigma, ≥98%); bovine basic trypsin (sigma, ≥10,000 BAEE); Calcium chloride (AR); Ammonium bicarbonate (AR); Acetic acid (AR).

In the following examples, nano-high-performance liquid chromatography-orbitrap high resolution mass spectrometry (NanoLC-Orbitrap MS) was used for selective ion scanning analysis under the following chromatographic conditions:

Nano-high-performance liquid UltiMate 3000 (ACCELA)

Column: Acclaim® PepMap RSLC (75 μm×15 cm, nanoViper C18, 2 μm, 100 A Thermo Fisher Scientific); Acclaim PepMap™ 100 (75 μm×2 cm, nanoViper C18, 3 μm, 100 A Thermo Fisher Scientific)

Column temperature: 50° C.

Mobile phase A: 2% acetonitrile+98% water+0.1% formic acid

Mobile phase B: 80% acetonitrile+20% water+0.1% formic acid

Loading: 2% acetonitrile+98% water

Flow rate: NC: 0.25 μL/min, loading flow rate: 0.3 μL/min

Injection volume: 1 μL

Gradient elution conditions

Gradient elution

Elution time (min)
Flow rate (μL/min)
A %
B %

0
0.25
96
4

5
0.25
96
4

65
0.25
78
22

70
0.25
10
90

75
0.25
96
4

76
0.25
96
4

In the following examples, the characteristic peptide segments were subjected to a mass spectrometry analysis in PRM mode under the following mass spectrometry conditions:

Q Exactive mass spectrometer (Thermo Fisher Scientific)

PRM mode

Running time: 5-75 min

Polarity: positive

Resolution: 17500

AGC target: 1e5

Maximum IT: 100 ms

Separation window: 1.0 m/z

Initial mass-to-charge ratio: Fixed first mass

NCE: 27%, 28%.

Example 1: Selection of Characteristic Peptide Segments

A mixed standard substance of α-lactalbumin, β-lactoglobulin, α-casein, and β-casein and a milk powder sample were subjected to a full-scanning by mass spectrometry, and the mass spectra thereof were shown in FIG. 1 and FIG. 2, respectively.

By using ExPASy PeptideMass website, four proteins obtained by retrieval in NCBI's database, α-lactalbumin, β-lactoglobulin, α-casein, and β-casein, were subjected to a simulated enzyme digestion (for the peptide segments produced by the simulated digestion, please see Table 2 below), and a comparation. The compared peptide segments were substituted to NCBI website for BLAST alignment analysis, and peptide segments with high response value and a sequence length of 5-25 amino acids were selected and finally determined as the specific peptide segments, which were:

characteristic peptide segment of α-lactalbumin (hereinafter also referred to as α-1a)-LDQWLCEK (as shown in SEQ ID NO.1),

characteristic peptide segment of β-lactoglobulin (hereinafter also referred to as β-1g)-TPEVDDEALEK (as shown in SEQ ID NO.3),

characteristic peptide segment of α-casein (hereinafter also referred to as α-cs)-FALPQYLK (as shown in SEQ ID NO.4),

characteristic peptide segment of β-casein (hereinafter also referred to as β-cs)-VLPVPQK (as shown in SEQ ID NO.2), respectively.

Specific information on the above four characteristic peptide segments was shown in Table 3, and their mass spectra in PRM mode were shown in FIG. 3.

The respective daughter ion information maps of the above four characteristic peptide segments were shown in FIGS. 4, 5, 6, and 7, respectively, from which it can be seen that the quantitative daughter ions selected in the experiment have higher response values in the detection process; FIG. 8 showed the daughter ion peaks of four peptide segments detected separately (here, they were combined into one diagram), to illustrate that they were independent peaks and did not interfere with each other during detection; in addition, the quantitative fragment ion information was shown in Table 4; and fragment ions with appropriate response value and mass number of each specific peptide segment were selected as quantitative ions.

Table 2 Peptide segments produced by simulated digestion of α-lactalbumin, β-lactoglobulin, α-casein, and β-casein

β-Lactoglobulin

Protein Sequence (as Shown in SEQ ID NO.5):

10 20 30 40

LIVTQTMKGL DIQKVAGTWY SLAMAASDIS LLDAQSAPLR

50 60 70 80

VYVEELKPTP EGDLEILLQK WENDECAQKk IIAEKtkIPA

90 100 110 120

VFKIDALNEN KVLVLDTDYK kYLLFCVENS AEPEQSLVCQ

130 140 150 160

CLVRTPEVDD EALEKFdkal kALPMHIRLS FNPTQLEEQC HI

Peptide Fragments by Theoretical Digestion (as Shown in SEQ ID NO.6-18, Respectively):

artif.

posi-
#
medifi-
modifi-
peptide

mass
tion
MC
cations(s)
cations
sequence

2707.3759
15-40
0

VAGTWYSLA

MAASDISLL

DA QSAPLR

2675.2336
102-124
0
Cys.CAM:
2846.2980
YLLFCMENS

106, 119

AEPEQSLVC

121

QC LVR

2313.2587
41-60
0

VYVEELKPT

PEGDLEILL

QK

1058.7843
149-162
0
Cys_CAM:
1715.8057
LSFNPTQLE

160

EQCHI

1245.5645
125-135
0

TPEVDDEAL

EK

1122.4520
61-69
0
Cys_CAM:
1179.4735
WENDECAQK

66

1065.5626
92-100
0

VLVLDTDYK

933.5437
1-8
0

LIVTQTMK

916.4734
84-91
0

IDALNENK

837.4763
142-148
0

ALPMHIR

674.4235
78-83
0

IPAVFK

673.3879
9-14
0

GLDIDQK

573.3606
71-75
0

BAEK

F Chain of Bovine α-Lactalbumin, Crystal Structure

Protein sequence (as shown in SEQ ID NO.19):

10 20 30 40

EQLTKCEVFR elkdlkGYGG VSLPEWYCTT FHTSGYDTQA

50 60 70 80

IVQNNDSTEY GLFQINNKIW CKDDQNPHSS NICNISCDKF

90 100 110 120

LDDDLTDDIM CVKkildkVG INYWLAHKAL CSEKLDQWLC EKl

Peptide fragments by theoretical digestion (as shown in SEQ ID NO.20-28, respectively):

artif.

posi-
#
modifi-
modifi-
peptide

mass
tion
MC
cations(s)
cations
sequence

4654.1467
17-58
0
Cys_CAM:
4711.1681
GYGGVSLPE

26

WVCTTFHTS

GY DTQAIV

QNNDSTEYG

LFQIN NK

1889.7752
63-79
0
Cys_CAM:
2003.8162
DDQNPHSSN

73, 77

ICNISCDK

1642.7338
80-93
0
Cys_CAM:
1699.7553
FLDDDLTDD

91

IMCVK

1200.6524
99-108
0

VGINYWLAH

K

1034.4975
115-122
0
Cys_CAM:
1091.5190
LDQWLCEK

120

653.3075
6-10
0
Cys_CAM:
710.3290
CEVFR

6

650.3178
109-114
0
Cys_CAM:
707.3392
ALCSEK

111

618.3457
1-58
0

EQLTK

549.2853
59-62
0
Cys_CAM:
606.3068
IWCK

61

α-S1-Casein, Partial [Bovine]

Protein sequence (as shown in SEQ ID NO.29):

10 20 30 40

mkLLILTCLV AVALARPKhp ikHQGLPQEV LNENLLRFFV

50 60 70 80

APFPEVFGKe kVNELSKDIG SESTEDQAME DIKQMEAESI

90 100 110 120

SSSEEIVPNS VEQKHIQKED VPSERYLGYL EQLLRlkkyk

130 140 150 160

VPQLEIVPNS AEERLHSMKE GIHAQQKEPM IGVNQELAYF YPE

Peptide fragments by theoretical digestion (as shown in SEQ ID NO.30-42, respectively):

artif.

posi-
#
modifi-
modifi-
peptide

mass
tion
MC
cation(s)
cations
sequence

2321.0813
74-94
0

QMEAESISS

SEEIVPNSV

EQ K

1899.8833
148-163
0

EPMIGVNQE

LAYFYPE

1767.7589
58-73
0

DIGSESTED

QAMEDIK

1759.9449
23-37
0

HQGLPQEVL

NENLLR

1694.0760
3-18
0
Cys_CAM:
1751.0975
LLILTCLVA

8

VALARPK

1580.8278
121-134
0

VPQLEIVPN

SAEER

1334.7299
38-49
0

FFVAPFPEV

FGK

1267.7045
106-115
0

YLGYLEQLLR

910.4741
140-147
0

EGIHAQQK

831.3843
99-105
0

EDVPSER

689.3828
52-57
0

VNELSK

615.3283
135-139
0

LHSMK

525.3143
95-98
0

HIQK

α-S2-Casein Precursor [Bovine]

Protein sequence (as shown in SEQ ID NO.43):

10 20 30 40

mkFFIFTCLL AVALAKNTME HVSSSEESII SQETYKqekN

50 60 70 80

MAINPSKENL CSTFCKEVVR NANEEEYSIG SSSEESAEVA

90 100 110 120

TEEVKITVDD KHYQKALNEI NQFYQKFPQY LQYLYOGPIV

130 140 150 160

LNPWDQVKrN AVPITPTLNR EQLSTSEENS KkTVDMESTE

170 180 190 200

VFTKktkLTE EEKnrLNFLK kISQRyqkFA LPQYLKTVYQ

210 220

HQKAMKPWIQ PKtkVIPYVR yl

Peptide fragments by theoretical digestion (as shown in SEQ ID NO.44-63, respectively):

artif.

modifi-

posi-
#
ca-
modifi-
peptide

mass
tion
MC
tions(s)
cations
sequence

2709.4075
107-128
0

FPQYLQYLY

QGPIVLNPW

DQ VK

2688.1642
61-85
0

NANEEEYSI

GSSSEESAE

VA TEEVK

2299.0394
17-36
0

NTMEHVSSS

EESIISQET

YK

1556.8909
3-16
0
Cys_CAM:
1613.9123
FFIFTCLLA

8

VALAK

1386.6487
153-164
0

TVDMESTEV

FTK

1367.6954
96-106
0

ALNEINQFY

QK

1251.5699
141-151
0

EQLSTSEEN

SK

1195.6793
130-140
0

NAVPITPTL

NR

1098.6128
204-212
0

AMKPWIQPK

1044.4489
48-56
0
Cys_CAM:
1158.
ENLCSTFCK

51, 55
4918

978.5611
189-196
0

FALPQYLK

903.4683
197-203
0

TVYQHQK

874.4451
40-47
0

NMAINPSK

748.3723
168-173
0

LTEEEK

746.4559
215-220
0

VIPYVR

690.3668
86-91
0

ITVDDK

634.3022
176-180
0

LNFLK

575.2936
92-95
0

HYQK

503.2936
182-185
0

ISQR

502.2983
57-60
0

EVVR

β-Casein

Protein sequence (as shown in SEQ ID NO.64):

10 20 30 40

mkVLILACLV ALALARELEE LNVPGEIVES LSSSEESITR

50 60 70 80

inkkiekFQS EEQQQTEDEL QDKIHPFAQT QSLVYPFPGP

90 100 110 120

IHNSLPQNIP PLTQTPVYVP PFLQPEVMGV SKvkEAMAPK

130 140 150 160

hkEMPFPKYP VEPFTESQSL TLTDVENLHL PLPLLQSWNH

170 180 190 200

QPHQPLPPTV MFPPQSVLSL SQSKVLPYPQ KAVPYPQRDM

210 220

PIQAFLLYGE PVLGPVRGPF PIIV

Peptide fragments by theoretical digestion (as shown in SEQ ID NO.65-75, respectively):

artif.

modifi-

ca-

posi-
#
tions
modifi-
peptide

mass
tion
MC
(s)
cations
sequence

6359.2558
129-184
0

YPVEPFTES

QSLTLTDVE

NL HLPLPL

LQSWMHQPH

QPLPPTVMF

PPQSVLSLS

QSK

5356.8594
64-112
0

IHPFAQTQS

LVYPFPGPI

MNSLPQNIP

PLTQTPVVV

PPFLQPEVM

GVSK

2646.2992
17-40
0

ELEELNVPG

EIVESLSSS

EE SITR

2186.1678
199-217
0

DMPIQAFLL

YQEPVLGPV

R

1981.8621
48-63
0

FQSEEQQQT

EDELQDK

1436.9177
3-16
0

VLILACLVA

LALAR

830.4519
192-196
0
Cys.
1495.9392
AVPYPQR

CAM:

8

780.4978
185-191
0

VLPVPQK

746.3698
123-128
0

EMPFPK

742.4497
218-224
0

GPFPIIV

646.3228
115-120
0

EAMAPK

TABLE 3

Information on characteristic peptide

segments

Mole-

Pro-
Peptide
cular

tein
segment
weight
Amino acid chain

β-lg
TPEVDDEALEK
623.29
Thr-Pro-Glu-Val-Asp-

(SEQ ID

Asp-Glu-Ala-Leu-Glu-

NO. 3)

Lys

α-la
LDQWLCEK
546.23
Leu-Asp-Gln-Trp-Leu-

(SEQ ID

Cys-Glu-Lys

NO. 1)

α-cs
FALPQYLK
490.19
Phe-Ala-Leu-Pro-Gln-

(SEQ ID

Tyr-Leu-Lys

NO. 4)

β-cs
VLPVPQK
390.75
Val-Leu-Pro-Val-Pro-

(SEQ ID

Gln-Lys

NO. 2)

TABLE 4

Information on quantitative fragment

ions

Daughter
Re-

ion mass
tention

Parent
number
time

particle
(KDa)
(min)

TPEVDDEALEK
199.10836
27.5

(SEQ ID NO. 3)

LDQWLCEK
268.16794
55.2

(SEQ ID NO. 1)

FALPQYLK
120.08216
57.8

(SEQ ID NO. 4)

VLPVPQK
372.2257
23.7

(SEQ ID NO. 2)

Example 2: Optimization of Enzymolysis Conditions, Selection of Substrate Concentration, as Well as Selection of Filter Membrane

Optimization of Enzymolysis Conditions:

In this experiment, milk powder samples under the brand names Sanyuan and Ailiyou (with a protein concentration of 11.6 g/100 g milk powder sample) were used as substrates, and subjected to enzymolysis at enzyme concentrations of 1:20, 1:40, 1:60, 1:80, and 1:100, respectively, according to the information provided by the product suppliers. As a result, an enzyme concentration of 1:20 and enzymolysis time of 28 h were selected based on variations in the peak area ratio of the characteristic peptide segments LDQWLCEK(SEQ ID NO.1)/VLPVPQK(SEQ ID NO.2) and variations in the peak area ratio of the characteristic peptide segments TPEVDDEALEK(SEQ ID NO.3)/FALPQYLK(SEQ ID NO.4) in the process of enzymolysis, both of which tended to be stable after enzymolysis for 28 h at the enzyme concentration of 1:20 (See FIG. 9 and FIG. 10 for details).

Selection of Substrate Concentration:

Milk powder samples were dissolved into solutions with ten protein concentration gradients between 0.1-1.0 mg/mL, which were then filtered roughly with pure acetic acid filter membrane with a pore size of 0.45 μm. 250 μL of sample solution was added to 150 μL of ammonium bicarbonate solution, followed by adding 10 μL of dithiothreitol solution, and kept in a water bath at 70° C. for 30 min. After cooling, 30 μL of iodoacetamide solution was added thereto, followed by standing for 30 min in the dark. After illuminating for 10 min, 10 μL of calcium chloride solution was added, followed by adding 50 μL of Trypsin solution, and then enzyme digestion was performed at 37° C. for 28 h, followed by adding 10 μL of acetic acid solution, and standing for 15 min to stop digestion. After filtration with 0.22 μm of polyethersulfone filter membrane, selective ion scanning analysis was carried out by nanoliter liquid chromatography. The results showed that when the protein concentration was below 0.4 mg/mL, the ratio of two characteristic peptide segments remained relatively stable after enzymolysis, indicating a good detection effect (See FIGS. 11 and 12).

Selection of Filter Membrane:

The pure acetic acid filter membrane having a large pore size of 0.45 nm was used to filter the milk powder sample preliminarily, to remove some additives, so as to avoid the impact thereof on the subsequent experiments and ensure the stability of the method. 0.22 μm of polyethersulfone filter membrane with extremely low protein adsorption was selected for filtration before running on machine.

Example 3: Detection Procedure of the Method of the Present Present Disclosure

1) Establishment of Standard Curve:

Four protein standard substances of α-lactalbumin, β-lactoglobulin, α-casein, and β-casein were used. Specifically, whey protein standard solution was prepared in accordance with α-lactalbumin and β-lactoglobulin accounting for 20% and 50% of whey protein, respectively (i.e., the contents of α-lactalbumin and β-lactoglobulin were 20% and 50%, respectively); and casein standard solution was prepared in accordance with α-casein and β-casein accounting for 50% and 40% of casein, respectively (i.e., the contents of α-casein and β-casein were 50% and 40%, respectively); and the prepared whey protein standard solution had the same concentration as the prepared casein standard solution.

Certain amounts of the whey protein standard solution and the casein standard solution prepared as above were mixed to prepare 1 mL of a mixed solution with a whey protein/casein ratio of 0.25, 0.43, 0.67, 1, 1.5, 2.33 (mass ratio), which was then detected for drawing standard curves; the standard curve of peak area ratio vs concentration ratio of characteristic peptide segments TPEVDDEALEK(SEQ ID NO.3)/FALPQYLK(SEQ ID NO.4) was shown in FIG. 13, and the standard curve of peak area ratio vs concentration ratio of characteristic peptide segments LDQWLCEK(SEQ ID NO.1)/VLPVPQK(SEQ ID NO.2) was shown in FIG. 14.

2) Treatment and Enzyme Digestion of Milk Powder Samples to be Tested:

dissolving the milk powder sample to be tested into a sample solution with a protein concentration of 0.2 mg/ml; subjecting the sample solution to rough filtration with a pure acetic acid filter membrane with a pore size of 0.45 μm; adding the roughly filtered sample solution into ammonium bicarbonate solution, followed by adding dithiothreitol solution, and placing the mixture in a water bath at 70° C. for 30 min; after cooling, adding iodoacetamide solution thereto, and standing for 30 min in the dark; then illuminating for 10 min, followed by adding calcium chloride solution thereto; adding trypsin solution to allow an enzyme digestion at 37° C. for 26-30 h; adding acetic acid solution to stop the enzyme digestion;

3) filtering the enzymolysis products from step 2) with polyethersulfone filter membrane, and then performing selective ion scanning analysis by mass spectrometry to detect the peak area ratios of characteristic peptide segments of β-lactoglobulin to α-casein and of α-lactalbumin to β-casein in the milk powder;

4) substituting the peak area ratio of the characteristic peptide segments of β-lactoglobulin to α-casein in the milk powder as detected from step 3) into the standard curve to determine the ratio M of whey protein to casein, and calculating the actual amounts of β-lactoglobulin and α-casein based on the ratio M thus determined;

and, substituting the peak area ratio of the characteristic peptide segments of α-lactalbumin to β-casein in the milk powder as detected from step 3) into the standard curve to determine the ratio N of whey protein to casein, and calculating the actual amounts of α-lactalbumin to β-casein based on the ratio N thus determined;

the actual amounts of β-lactoglobulin and α-casein are calculated by the following formulas, respectively:

$β - lactoglobulin = \frac{M 1}{M 1 + M 2} X * 50 %, α - casein = \frac{M 2}{M 1 + M 2} X * 50 %;$

wherein, M1 was the preceding term in the ratio M of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of β-lactoglobulin to α-casein, and M2 was the latter term in the ratio M of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of β-lactoglobulin to α-casein, with the provisions of: M=M1/M2, and M1+M2=1; and X is the total protein concentration of the sample; the actual amounts of α-lactalbumin and β-casein are calculated by the following formulas, respectively:

$α - la = \frac{N 1}{N 1 + N 2} X * 20 %, β - cs = \frac{N 2}{N 1 + N 2} X * 40 %;$

wherein, N1 was the preceding term in the ratio N of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of α-lactalbumin to β-casein, and N2 was the latter term in the ratio N of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of α-lactalbumin to β-casein, with the provisions of: N=N1/N2, and N1+N2=1; and X is the total protein concentration of the sample;

5) acquiring the actual contents of whey protein and casein, and/or the actual ratio of whey protein/casein based on the actual amounts of α-lactalbumin, β-casein, β-lactoglobulin, and α-casein obtained from step 4);

the formula for calculating the actual content of whey protein was:

$\frac{\frac{N 1}{N 1 + N 2} X * 20 % + \frac{M 1}{M 1 + M 2} X * 50 %}{0.7}$

the formula for calculating the actual content of casein was:

$\frac{\frac{M 1}{M 1 + M 2} X * 50 % + \frac{N 2}{N 1 + N 2} X * 40 %}{0.9}$

the formula for calculating the actual ratio of whey protein/casein was:

wherein, N1 was the preceding term in the ratio N of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of α-lactalbumin to β-casein, and N2 was the latter term in the ratio N of whey protein:casein as determined based on the peak area ratio of characteristic peptide segments of α-lactalbumin to β-casein, with the provisions of: N=N1/N2, and N1+N2=1; and, wherein, X is the total protein concentration of the sample.

Example 4: Methodology Validation on the Detection Method of the Present Disclosure by Using Desalted Whey Powder

Standard Addition Recovery Rate

Desalted whey powder was used as the standard sample, and was known to have a protein content of 12% according to its product annotation, which was almost made up of whey protein, with only a very little or negligible amount of casein, as detected by an instrument; the primary mass spectrum of the desalted whey powder was shown in FIG. 15, and analyzed to obtain its composition as shown in FIG. 16.

the detection method of the present disclosure was verified by using the desalted whey powder and the results were shown in Table 5 below.

TABLE 5

Added amount
Theoretical
Detection
Recovery
RSD

(mg)
value (mg)
value (mg)
rate (%)
(%)

Substrate
0
/
19.48
/
7.35

Desalted
3.60
23.08
23.03
98.63
0.84

whey
7.20
26.68
26.90
103.06
7.42

powder
10.80
30.28
31.72
113.33
1.83

14.40
33.88
34.11
101.62
0.84

According to Table 5, the standard addition recovery rate of the desalted whey powder detected by the detection method of the present disclosure was 98.63%-113.33%, and the corresponding RSD was 0.84%-7.42%.

Example 5: Methodology Validation on the Detection Method of the Present Disclosure by Using Commercial Formula Milk Powder

According to the detection method of the present disclosure described in Example 3, three brands of commercial formula milk powder were tested, in which: 6 groups of parallel tests were conducted once a day for 3 days to verify the repeatability and precision of the detection method of the present disclosure; the detection results of the three brands of commercial formula milk powder were shown in Tables 6-8, in which, LD represents the characteristic peptide segment of α-lactalbumin, LDQWLCEK (as shown in SEQ ID NO.1), TP represents the characteristic peptide segment of β-lactoglobulin, TPEVDDEALEK (as shown in SEQ ID NO.3), FAL represents the characteristic peptide segment of α-casein, FALPQYLK (as shown in SEQ ID NO.4), and VL represents the characteristic peptide segment of β-casein, VLPVPQK (as shown in SEQ ID NO.2).

TABLE 6

Repeatability and precision results of the detection of 1# brand

formula milk powder (Sanyuan, Enbeiyi, Section 1)

Days

1
2
3

TP/FAL
LD/VL
TP/FAL
LD/VL
TP/FAL
LD/VL

5.661328
0.596471
5.943357
0.593253
5.854161
0.594823

6.698231
0.591934
6.182401
0.636411
6.215530
0.601842

5.833083
0.626097
6.463053
0.658798
6.251452
0.620248

6.070490
0.592644
5.611366
0.614108
5.950025
0.581455

6.191200
0.604171
5.853564
0.582013
6.072519
0.562768

6.120052
0.558423
6.115780
0.597187
6.182007
0.561523

Average
6.095731
0.594957
6.028253
0.613628
6.087616
0.587110

SD
0.355257
0.021937
0.293936
0.029136
0.158603
0.023038

RSD (%)
0.058280
0.036871
0.04876
0.047482
0.026053
0.039241

Average
6.070533

0.598565

between

groups

SD
0.036840

0.013623

RSD (%)
0.006069

0.022759

TABLE 7

Repeatability and precision results of the detection of 2# brand

formula milk powder (Sanyuan, Aixinbao, Section 1)

Days

1
2
3

TP/FAL
LD/VL
TP/FAL
LD/VL
TP/FAL
LD/VL

6.255670
0.611835
5.629679
0.615912
5.666182
0.586044

5.760567
0.605571
5.619842
0.648726
5.724010
0.538855

6.331991
0.590981
5.304704
0.630166
5.634282
0.574862

6.156652
0.634878
5.836408
0.631432
5.471585
0.574179

5.802848
0.562343
5.592876
0.613239
5.762156
0.532703

5.901041
0.552298
5.636404
0.627743
5.465830
0.576933

Average
6.034795
0.592984
5.603319
0.627870
5.620674
0.563929

SD
0.244480
0.031200
0.170689
0.012728
0.125822
0.022300

RSD (%)
0.040512
0.052615
0.030462
0.020272
0.022386
0.039545

Average
5.834348

0.605599

between

groups

SD
0.244257

0.032015

RSD (%)
0.041865

0.052864

TABLE 8

Repeatability and precision results of the detection of 3# brand

formula milk powder (Sanyuan, Ailiyou, Section 1)

Days

1
2
3

TP/FAL
LD/VL
TP/FAL
LD/VL
TP/FAL
LD/VL

7.453970
0.531694
7.704645
0.561678
6.723771
0.593539

7.259978
0.595509
7.603946
0.570701
8.520871
0.662325

7.114793
0.510083
7.885622
0.638107
8.433776
0.676738

7.299271
0.476919
7.420642
0.548663
8.070415
0.759728

7.429340
0.553053
7.749015
0.577207
8.319099
0.720309

7.765910
0.583946
7.761472
0.602464
7.881502
0.613721

Average
7.387210
0.541867
7.687557
0.583137
7.991573
0.671060

SD
0.222611
0.044956
0.159372
0.032354
0.664624
0.062759

RSD (%)
0.030135
0.082965
0.020731
0.055483
0.083166
0.093522

Average
7.688780

0.598688

between

groups

SD
0.302183

0.065985

RSD (%)
0.039302

0.110217

According to Tables 6-8, the RSD within groups for the above detections was in the range of 2.03%-9.35%, and the RSD between groups was in the range of 0.61%-11.02%, indicating that the detection method of the present disclosure had good repeatability and precision.

Example 6: Detection Example of the Detection Method of the Present Disclosure

According to the detection method of the present disclosure described in Example 3, the content of whey protein in commercial formula milk powder (Abbott, Classic Enmeili, Section 1) was detected, and the specific procedure was as follows:

To 0.2 g commercial formula milk powder (Abbott, Classic Enmeili Section 1), ultrapure water was added to a fixed volume of 200 mL. The obtained sample solution was then filtered roughly with pure acetic acid filter membrane with a pore size of 0.45 μm. Then 250 μL of the filtered sample solution was added to 150 μL of ammonium bicarbonate solution, followed by adding 10 μL of dithiothreitol solution, and kept in a water bath at 70° C. for 30 min. After cooling to room temperature, 30 μL of iodoacetamide solution was added thereto, and allowed to stand for 30 min in the dark. After illuminating for 10 min, 10 μL of calcium chloride solution was added thereto, followed by adding 50 μL of Trypsin solution to allow an enzyme digestion at 37° C. for 28 h, and further followed by adding 10 μL of acetic acid solution and standing for 15 min to stop digestion. Filtration was carried out with 0.22 μm of polyethersulfone filter membrane prior to detection on the machine. It was calculated that whey protein accounted for 61.77% of the total protein content in the sample.

Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present disclosure, but not to limit it; although the present disclosure has been described in detail with reference to the foregoing embodiments, it will be understood by one of ordinary skill in the art that the technical solutions described in the foregoing embodiments can still be modified or some technical features can be equivalently substituted; however, these modifications or substitutions do not make the essence of the corresponding technical solutions departing from the spirit and scope of the technical solutions of various embodiments of the present disclosure.

	Number	Date	Country
Parent	PCT/CN2021/143234	Dec 2021	US
Child	17871549		US

METHOD FOR DETECTING CONTENTS OF WHEY PROTEIN AND CASEIN, AND/OR RATIO THEREOF IN MILK POWDER

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

Priority Claims (1)

RELATED APPLICATIONS

Continuations (1)